Fuse Science, Inc. CEO Brian Tuffin and Tiger Woods to Appear on CNBC’s “Closing Bell with Maria Bartiromo”
MIAMI LAKES, Fla., Oct. 19, 2012 /PRNewswire/ — Fuse Science, Inc. (OTCQB: DROP), (www.fusescience.com) an innovative company that possesses proprietary technologies set to redefine how consumers receive energy, medicines, vitamins and minerals, today announced that CEO Brian Tuffin and Tiger Woods are scheduled to appear together today on CNBC’s “Closing Bell with Maria Bartiromo” shortly after 4:00 PM ET.
Mr. Tuffin will be discussing the recent scientific results achieved by Fuse Science that they believe will provide a more efficient way to deliver medicine, nutrients and other actives to the human body.
About Fuse Science, Inc.
Fuse Science, Inc. (OTCQB: DROP), is an innovative holdings company based in Miami Lakes, Florida. Fuse Science holds the rights to new, patent-pending technologies poised to redefine how consumers receive energy, medicines, vitamins and minerals. The company maintains the rights to sublingual and transdermal delivery systems for bioactive agents that can now, for the first time, effectively encapsulate and charge many varying molecules in order to produce complete product formulations which can bypass the gastrointestinal tract and enter the blood stream directly either through a topical gel roll-on or alternatively in a concentrated “DROP” form that is simply applied under the tongue. The Fuse Science technology is designed to accelerate conveyance of medicines or nutrients relative to traditional pills and liquids and can enhance how consumers receive these products. Information about Fuse Science is available online at www.fusescience.com and www.poweredbyfuse.com or by calling 305-503-FUSE (3873).
For more information: To schedule an interview: Fuse Science, Inc. Gus DeQuesada Investor Relations Michelsen Advertising Direct: (305) 503-3873, Ext. 2 C-305-733-1410 / 786-488-7138 Email: firstname.lastname@example.org email@example.com
Safe Harbor Statement
Certain statements and information included in this release may constitute “forward-looking statements” as defined in the Federal Private Securities Litigation Reform Act of 1995. Such forward-looking statements involve known and unknown risks, uncertainties and other factors which may cause the actual results, performance or achievements of the company to be materially different from any future results, performance or achievements expressed or implied in such statements. Additional discussion of factors that could cause actual results to differ materially from management’s projections, estimates and expectations is contained in the Company’s SEC filings. The Company assumes no obligation to update any forward-looking statements as a result of new information, future events or developments, except as required by federal securities laws.
SOURCE Fuse Science, Inc.